Figure 2
Figure 2. Identification of miR-150 targets by gene expression analysis. (A) Microarray data for protein-coding gene expression (Affymetrix HG-U133+2 GeneChips) were compared in CLL samples stratified based on low (n = 32) vs high (n = 32) levels of miR-150. The samples from the lowest and highest tercile were compared (SAM in MeV, fold change >1.5, false discovery rate <0.1). This analysis identified differential expression of 58 genes (72 probes) between CLL cells expressing low vs high levels of miR-150. GAB1 and FOXP1 are marked with a black arrow. (B) The evolutionary conserved binding sides for miR-150 in GAB1 and FOXP1 3′UTR (TargetScan). (C-E) The association between miR-150 levels and the expression of mRNAs for GAB1 (C), FOXP1 (D), or c-MYB (E) in a validation cohort of 60 CLL samples. Each point represents the average value for gene expression from 10 CLL samples. The standard deviation about the mean is indicated by error bars.

Identification of miR-150 targets by gene expression analysis. (A) Microarray data for protein-coding gene expression (Affymetrix HG-U133+2 GeneChips) were compared in CLL samples stratified based on low (n = 32) vs high (n = 32) levels of miR-150. The samples from the lowest and highest tercile were compared (SAM in MeV, fold change >1.5, false discovery rate <0.1). This analysis identified differential expression of 58 genes (72 probes) between CLL cells expressing low vs high levels of miR-150. GAB1 and FOXP1 are marked with a black arrow. (B) The evolutionary conserved binding sides for miR-150 in GAB1 and FOXP1 3′UTR (TargetScan). (C-E) The association between miR-150 levels and the expression of mRNAs for GAB1 (C), FOXP1 (D), or c-MYB (E) in a validation cohort of 60 CLL samples. Each point represents the average value for gene expression from 10 CLL samples. The standard deviation about the mean is indicated by error bars.

Close Modal

or Create an Account

Close Modal
Close Modal